EurekaMag.com logo
+ Translate

Efficacy and safety of immunizing cats against pox with the MVA attenuated strain of vaccinia virus


, : Efficacy and safety of immunizing cats against pox with the MVA attenuated strain of vaccinia virus. Untersuchungen uber die Wirksamkeit und Unschadlichkeit einer Schutzimpfung von Katzen gegen Pocken mit MVA Lebendimpfstoff: 65 pp.

About 2% of German cats possessed antibody to orthopoxvirus, and cases of cat pox were reported occasionally. Cats were successfully immunized with 107 CCID50 of "MVA" (Modified Vaccinia Ankara) vaccine.

Accession: 002367323

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Bengelsdorff, H.-J.; Schneider, B., 1962: Safety and efficacy of attenuated fowl pox virus for immunizing chicks and chickens. Fowl pox strains varied in ability to produce generalized infection when injected into day-old chicks. A commercial vaccine strain was practically harmless, even at 100 times the protective dose. Skin reactions after cutaneous application of virus...

Black, J.G.; Lawson, K.F., 1980: The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Foxes given ERA rabies vaccine baits were challenged one, six, 12 and 24 months later and showed a resistance to challenge in 80%, 78%, 60% and 44% of individuals respectively. All animals showing seroconversion following vaccination resisted chal...

Hochstein-Mintzel, V.; Hänichen, T.; Huber, H.C.; Stickl, H., 1975: An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola. The attenuated MVA strain of vaccinia virus was previously shown to be innocuous and immunogenic at intracutaneous injection. It was therefore suggested for clinical trial. Preliminary results in human vaccinees are promising. The present experime...

Blancou, J.; Artois, M.; Brochier, B.; Thomas, I.; Pastoret, P.P.; Desmettre, P.; Languet, B.; Kieny, M.P., 1989: Safety and efficacy of an antirabies vaccine (vaccinia-rabies recombinant virus) given by mouth to foxes, dogs and cats. The DNA corresponding to the gene coding for glycoprotein G of rabies virus was inserted into the genome of vaccinia virus, and thus a recombinant virus was synthesized, expressing only the glycoprotein G. This was given in liquid form to foxes, d...

Ramírez, J.C.; Gherardi, M.M.; Rodríguez, D.; Esteban, M., 2000: Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. A problem associated with the use of vaccinia virus recombinants as vaccines is the existence of a large human population with preexisting immunity to the vector. Here we showed that after a booster with attenuated recombinant modified vaccinia vi...

Sutter, G.; Moss, B., 1995: Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus. Developments in Biological Standardization 84: 195-200

Jones, L.; Ahmad, S.; Simon, V.; Waddell, D.; Yilma, T., 2000: Increased safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccinia virus vaccines. Journal of Medical Primatology 29(3-4): 277, August

Zhao, Y.; Cheng, J-long.; Liu, X-yu.; Zhao, J.; Hu, Y-xin.; Zhang, G-zhong., 2016: Safety and efficacy of an attenuated Chinese QX-like infectious bronchitis virus strain as a candidate vaccine. Infectious bronchitis (IB) is a highly contagious respiratory and urogenital disease of chickens caused by infectious bronchitis virus (IBV). This disease is of considerable economic importance and is primarily controlled through biosecurity and i...

Geerligs, H.J.; Boelm, G-J.; Meinders, C.A.M.; Stuurman, B.G.E.; Symons, J.; Tarres-Call, J.; Bru, T.; Vila, R.; Mombarg, M.; Karaca, K.; Wijmenga, W.; Kumar, M., 2011: Efficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens. The attenuation of infectious bronchitis (IB) QX-like virus strain L1148 is described. The virus was passaged multiple times in embryonated specific pathogen free (SPF) chicken eggs, and at different passage levels samples were tested for safety f...

Kanesa Thasan, N.; Smucny, J.J.; Hoke, C.H.Jr.; Marks, D.H.; Konishi, E.; Kurane, I.; Tang, D.B.; Vaughn, D.W.; Mason, P.W.; Shope, R.E., 2000: Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus: Poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. A controlled, randomized, double-blind clinical trial evaluated whether two attenuated recombinant poxviruses with identical Japanese encephalitis virus (JEV) gene insertions, NYVAC-JEV and ALVAC-JEV, were safe and immunogenic in volunteers. Group...